CORT: Summary for Corcept Therapeutics Incorporat - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 11:54am EST - Canadian Markets close in 4 hours and 6 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Corcept Therapeutics Inc. (CORT)

At 11:29 EST: 2.145 USD

0.075 (3.62%)

MORE ON CORT

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Corcept Therapeutics Incorporat (NCM:CORT) Delayed quote data

Last Trade:	2.145 USD
Trade Time:	11:29AM EST
Change:	0.075 (3.62%)
Prev Close:	2.07
Open:	2.09
Bid:	2.13 x 100
Ask:	2.16 x 200
1y Target Est:	6.50

Day's Range:	2.06 - 2.20
52wk Range:	0.73 - 3.10
Volume:	4,450
Avg Vol (3m):	54,795.5
Market Cap:	134.01M
P/E (ttm):	N/A
EPS (ttm):	-0.426
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CORT to Portfolio

Download Data

HEADLINES

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
	EDGAR Online (Thu, Nov 12)

•	New Star Analyst Rankings for Corcept Therapeutics Incorporat
	StarMine (Wed, Nov 11)

•	Corcept 3Q loss narrows on lower costs
	AP (Tue, Nov 10)

•	Corcept trims Q3 loss to $4.7M
	at bizjournals.com (Tue, Nov 10)

•	Corcept cuts Q3 loss to $4.7 million
	at bizjournals.com (Tue, Nov 10)

•	Corcept Therapeutics Announces Recent Highlights and Third Quarter 2009 Financial Results
	Marketwire (Tue, Nov 10)

•	Q3 2009 CORCEPT THERAPEUTICS INC Earnings Release - Time Not Supplied
	CCBN (Mon, Nov 9)

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
	EDGAR Online (Wed, Oct 14)

•	Corcept Therapeutics: Pump Up the Volume
	at TheStreet.com (Tue, Oct 13)

•	Corcept to raise $18M in sale of stock and options
	AP (Tue, Oct 13)

More Headlines for CORT...

ANALYST

EPS Est (next year) (Dec-09) :	-0.40
EPS Est (in 2 years) (Dec-10) :	-0.35
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the development of drugs for the treatment of severe metabolic and psychiatric disorders.

Full Company Profile

Add to Portfolio

Email to a Friend

•